Increased Duration of Dual Pegylated Interferon and Ribavirin Therapy for Genotype 1 Hepatitis C Post-liver Transplantation Increases Sustained Virologic Response: A Retrospective Review

BACKGROUND/AIM: In patients with advanced post-transplant hepatitis C virus (HCV) recurrence, antiviral treatment (AVT) with interferon and ribavirin is indicated to prevent graft failure. The aim of this study was to determine and report Canadian data with respect to the safety, efficacy, and spont...

Descripción completa

Detalles Bibliográficos
Autores principales: Wells, Malcolm M., Roth, Lee S., Marotta, Paul, Levstik, Mark, Mason, Andrew L., Bain, Vincent G., Chandok, Natasha, Aljudaibi, Bandar M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793474/
https://www.ncbi.nlm.nih.gov/pubmed/24045596
http://dx.doi.org/10.4103/1319-3767.118133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793474/
https://www.ncbi.nlm.nih.gov/pubmed/24045596
http://dx.doi.org/10.4103/1319-3767.118133

Ejemplares similares